| CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
0.557 |
Evidence |
O
|
| CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
0.557 |
Evidence |
|
| CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
DRD1 |
DRD1: D(1A) dopamine receptor |
0.557 |
Evidence |
|
| CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
FPR1 |
FPR1: fMet-Leu-Phe receptor |
0.557 |
Evidence |
|
| CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
0.557 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
GRK1 |
GRK1, RHOK: Rhodopsin kinase precursor |
0.557 |
Evidence |
|
| IL3 |
IL3: Interleukin-3 precursor |
IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
0.557 |
Evidence |
|
| HCK |
IPI00029769 |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.557 |
Evidence |
|
| HCK |
IPI00029769 |
MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
0.557 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.557 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
0.557 |
Evidence |
|
| MME |
MME, EPN: Neprilysin |
EDN2 |
EDN2: Endothelin-2 precursor |
0.557 |
Evidence |
|
| MME |
MME, EPN: Neprilysin |
EDN3 |
EDN3: Endothelin-3 precursor |
0.557 |
Evidence |
|
| SERPINA6 |
SERPINA6, CBG: Corticosteroid-binding globulin precursor |
ST14 |
ST14, PRSS14, SNC19, TADG15: Suppressor of tumorigenicity protein 14 |
0.557 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.557 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.557 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
0.557 |
Evidence |
|
| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
0.557 |
Evidence |
|
| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
PEA15 |
PEA15: Astrocytic phosphoprotein PEA-15 |
0.557 |
Evidence |
|
| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
TRAF1 |
TRAF1, EBI6: TNF receptor-associated factor 1 |
0.557 |
Evidence |
|
| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
CIITA |
CIITA, MHC2TA: MHC class II transactivator |
0.557 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
0.557 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
IL8 |
IL8: Interleukin-8 precursor |
0.557 |
Evidence |
|
| RHO |
RHO, OPN2: Rhodopsin |
CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
0.557 |
Evidence |
|
| ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.557 |
Evidence |
|